Home > Maligne hematologie > Myeloïde ziekten > Acute myeloïde leukemie > AML (incl. APL) > Enhance-3

Enhance-3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Magrolimab versus Placebo in Combination with Venetoclax and Azacitidine in Newly Diagnosed, Previously Untreated Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 29-5-2024, 1:51